As of Monday trading on November 13th, Impax Laboratories Inc. (NASDAQ:$IPXL) plunged a cool 5.74%, or a loss of $-1.05 per share, to close at $17.25.
Impax Laboratories is a pharmaceutical company, developing and commercializing brand-name pharmaceuticals. It is based out of Hayward, CA, and home to 1,495 employees. Further, Impax is a component of the Russell 2000. The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It is maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.
After opening the day at $18.10, shares of Impax traded as high as $18.58 and as low as $17.10. Volume was 1.53 million shares over 6,874 trades, against an average daily volume of 1.8 million shares and a total float of 64.17 million.
As a result of the decline, Impax now sees a market cap of $1.28 billion. In the last year, shares of Impax have traded between a range of $25.70 and $7.75. The 50-day SMA is currently $20.55, and the 200-day SMA is $16.21.
Featured Image: twitter
